Compound 2439
Identifiers
- Canonical SMILES:
F[C@H]1CNC[C@H]1Oc1ccc(Cl)cc1-c1ccnc2cc(CN3C(=O)CCC3=O)sc12
- IUPAC name:
1-{[7-(5-chloro-2-{[(3R,4S)-4-fluoropyrrolidin-3-yl]oxy}phenyl)thieno[3,2-b]pyridin-2-yl]methyl}pyrrolidine-2,5-dione
- InChi:
InChI=1S/C22H19ClFN3O3S/c23-12-1-2-18(30-19-10-25-9-16(19)24)15(7-12)14-5-6-26-17-8-13(31-22(14)17)11-27-20(28)3-4-21(27)29/h1-2,5-8,16,19,25H,3-4,9-11H2/t16-,19+/m0/s1
- InChiKey:
JJPFTAGLDCWDFZ-QFBILLFUSA-N
External links
![]() 138610279 |
![]() CHEMBL4647687 |
R3Y |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
USP7 / Ubiquitin | 6.68 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 459.08 g/mol | |||
HBA | 6 | |||
HBD | 1 | |||
HBA + HBD | 7 | |||
AlogP | 3.01 | |||
TPSA | 76.11 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1021/acs.jmedchem.0c00245 | 22 | UBP7 Q93009 |
UBB P0CG47 |
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 6.68 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4781 | PF-00356231 | DB03367 | |
0.4651 | 2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE | DB07605 | |
0.4448 | 2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide | DB06969 | |
0.4330 | Sitravatinib | DB15036 | |
0.4286 | N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE | DB08031 | |
0.4251 | 1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine | DB06848 | |
0.4178 | Glesatinib | DB06302 | |
0.4167 | PF-06650833 | DB15143 | |
0.4156 | (1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid | DB07189 | |
0.4120 | 9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE | DB07006 | |
0.4096 | RPR131247 | DB02744 | |
0.4064 | MAX-40279 | DB15191 | |
0.4024 | (2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,4-DICARBOXYLIC ACID | DB07200 | |
0.4023 | CRS-3123 | DB12262 | |
0.3977 | THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE | DB07261 |